Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice02.08.2021 455

The overall diagnostic yield of massively parallel sequencing (MPS) based-tests in patients with chronic kidney disease (CKD) is around 30% for pediatric cases and 6-30% for adult cases. These figures should encourage nephrologists to frequently use genetic testing as a diagnostic means for their patients, but in reality several barriers appear to hinder the implementation of NGS diagnostics in routine clinical practice.

MIRCIM 2021 with EFIM and ISIM Sessions14.04.2021 426

It is a great pleasure to invite you to join the 6th McMaster International Review Course in Internal Medicine (MIRCIM), which will be held online May 11-June 17, 2021.

Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-1915.03.2021 778

Haemodialysis patients are extremely vulnerable to COVID-19. Their immune response after infection is unclear. We have found high seroconversion rates in this population with 95% developing antibodies. It is unclear if and how long these antibodies persist. Here we investigate this with serial antibody testing.


Doubtless that CAFU is now better structured to promote and develop businesses and sustainable projects between France and Uzbekistan. Accordingly, let us introduce you with Mr. Abduaziz HAKIMOV, a long-standing CAFU member and General Manager of Euromedex for Central Asian and Caucasus countries, who kindly accepted to invest more time and energy to lead the Uzbek CAFU branch as an Executive Director. Warm congratulations to Mr. HAKIMOV: we wish him nothing less than success and happiness within his mandate, and beyond…

EFIM has joined European Alliance for Value in Health16.11.2020 1040

Today, EFIM joined the 11 associations to form the European Alliance for Value in Health in order to connect different stakeholders to create conditions and inspire others. The Alliance represents a broad group of European associations representing patients, scientific and professional societies, healthcare managers, hospitals, regional health authorities and life-science industries....